Skip to main content
. 2020 Oct 20;7(1):e000430. doi: 10.1136/lupus-2020-000430

Table 1.

Strategies and evidence level for maximising hydroxychloroquine/chloroquine treatment in CLE

Strategies Evidence level*
Pre antimalarial treatment considerations
 Smoking cessation 2B
 Photoprotection: SPF 70 or greater, sun-protective clothing, UV avoidance 1B
 Possible Polypodium leucotomos supplementation 5
Medication compliance
 Measure HCQ drug levels after ≥2 months 1B
 Full daily doses instead of split doses 5
 GI upset: switch to nightly HCQ dosing, titrate HCQ gradually 5

*Evidence levels adapted from the Oxford Centre for Evidence-Based Medicine.

CLE, cutaneous lupus erythematosus; GI, gastrointestinal; HCQ, hydroxychloroquine; SPF, sun protection factor; UV, ultraviolet.